A detailed history of Genesee Capital Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Genesee Capital Advisors, LLC holds 892 shares of DHR stock, worth $210,369. This represents 0.12% of its overall portfolio holdings.

Number of Shares
892
Previous 891 0.11%
Holding current value
$210,369
Previous $222,000 11.26%
% of portfolio
0.12%
Previous 0.11%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$239.25 - $280.76 $239 - $280
1 Added 0.11%
892 $247,000
Q2 2024

Jul 18, 2024

BUY
$235.51 - $267.98 $235 - $267
1 Added 0.11%
891 $222,000
Q1 2024

Apr 22, 2024

BUY
$224.58 - $256.19 $224 - $256
1 Added 0.11%
890 $222,000
Q4 2023

Jan 29, 2024

BUY
$185.1 - $233.13 $185 - $233
1 Added 0.11%
889 $205,000
Q3 2023

Oct 24, 2023

BUY
$233.08 - $265.59 $233 - $265
1 Added 0.11%
888 $220,000
Q2 2023

Jul 17, 2023

SELL
$224.99 - $256.14 $1.52 Million - $1.73 Million
-6,758 Reduced 88.4%
887 $212,000
Q1 2023

Apr 18, 2023

SELL
$239.75 - $277.0 $43,634 - $50,414
-182 Reduced 2.33%
7,645 $1.93 Million
Q4 2022

Jan 20, 2023

SELL
$241.42 - $282.29 $120,710 - $141,145
-500 Reduced 6.0%
7,827 $0
Q3 2022

Oct 20, 2022

SELL
$247.06 - $1507.4 $26,188 - $159,784
-106 Reduced 1.26%
8,327 $2.15 Million
Q2 2022

Jul 19, 2022

SELL
$237.11 - $299.66 $263,666 - $333,221
-1,112 Reduced 11.65%
8,433 $2.14 Million
Q1 2022

May 25, 2022

SELL
$257.27 - $315.76 $35,503 - $43,574
-138 Reduced 1.43%
9,545 $2.8 Million
Q4 2021

Jan 25, 2022

SELL
$292.08 - $329.01 $54,618 - $61,524
-187 Reduced 1.89%
9,683 $3.19 Million
Q3 2021

Oct 14, 2021

BUY
$272.21 - $332.43 $2.69 Million - $3.28 Million
9,870 New
9,870 $3.01 Million
Q2 2021

Jul 20, 2021

SELL
$225.08 - $271.69 $2.32 Million - $2.8 Million
-10,317 Closed
0 $0
Q1 2021

Apr 16, 2021

SELL
$212.38 - $245.9 $12,742 - $14,754
-60 Reduced 0.58%
10,317 $2.32 Million
Q4 2020

Jan 19, 2021

SELL
$212.5 - $245.46 $6,375 - $7,363
-30 Reduced 0.29%
10,377 $2.31 Million
Q3 2020

Oct 29, 2020

SELL
$177.16 - $215.33 $54,742 - $66,536
-309 Reduced 2.88%
10,407 $2.24 Million
Q2 2020

Jul 20, 2020

SELL
$128.7 - $176.83 $308,365 - $423,684
-2,396 Reduced 18.27%
10,716 $1.89 Million
Q1 2020

Apr 16, 2020

SELL
$121.39 - $169.05 $462,981 - $644,756
-3,814 Reduced 22.53%
13,112 $1.81 Million
Q4 2019

Jan 14, 2020

SELL
$133.47 - $153.48 $42,710 - $49,113
-320 Reduced 1.86%
16,926 $2.6 Million
Q3 2019

Oct 15, 2019

BUY
$135.4 - $146.47 $12,456 - $13,475
92 Added 0.54%
17,246 $2.49 Million
Q2 2019

Jul 19, 2019

SELL
$124.88 - $143.73 $74,553 - $85,806
-597 Reduced 3.36%
17,154 $2.45 Million
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $114,410 - $155,043
1,172 Added 7.07%
17,751 $2.34 Million
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $1.57 Million - $1.82 Million
16,579 New
16,579 $1.71 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Genesee Capital Advisors, LLC Portfolio

Follow Genesee Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Genesee Capital Advisors, LLC with notifications on news.